Clinical Trials · NCT04871204

Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric Cancer

CompletedPhase 2Octreotide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Fredrik Klevebro
Enrollment
20
Start date
Jun 2021
Locations
1 site, Sweden
Primary endpoint
Weight change in percent (%)
View Octreotide compound reference